首页 | 本学科首页   官方微博 | 高级检索  
     


Multifocal skeletal tuberculosis: Experience in diagnosis and treatment
Authors:Liang Hong  Jin-Guo Wu  Ji-Guang Ding  Xiao-Yang Wang  Ming-Hua Zheng  Rong-Quan Fu  Wen-Bing Li  Wen-Xian Peng  Wen-fei He  Qing-Feng Sun
Affiliation:1. Department of Infectious Diseases, The Third Affiliated Hospital to Wenzhou Medical College, Rui’an, Zhejiang, 108, Wan song Road, Rui’an, 325200 Zhejiang, China;2. Department of Radiology, The Third Affiliated Hospital to Wenzhou Medical College, Rui’an, Zhejiang, 325200, China;3. Department of Infectious Diseases, The First Affiliated Hospital to Wenzhou Medical College, Wenzhou, Zhejiang, 325000, China;4. Department of Natural Products Chemistry, School of Pharmacy, Wenzhou Medical College, Wenzhou 325035, China
Abstract:

Objectives

Multifocal skeletal tuberculosis (MSTB) is an uncommon presentation of skeletal tuberculosis. In order to provide more clinically meaningful information on the diagnosis and management of MSTB, we present a case of MSTB with multiple tuberculous lesions in multiple locations, along with a review of 13 MSTB cases from different studies.

Patients and methods

A 29-year-old male patient with a one-year history of back pain was initially diagnosed with ankylosing spondylitis and arthritis deformans, and received treatment with oral glucocorticosteroid and leflunomide for 24 weeks. The back pain worsened with weight loss and fever one month prior to admission to our hospital. The diagnosis, MSTB, with 26 tuberculous lesions in 19 locations, was made by clinical findings, bone scan (computed topography and Tc-99m HDP scintigraphy), and bone marrow smear.

Result

Multiple antituberculous drugs, with supportive and immune-enhancing therapies cured the patient.

Conclusions

This case indicates that MSTB may develop in patients on long-term immunosuppressive drugs. In addition, our experience, along with previously reported data, suggest that strong clinical suspicion is required for an early diagnosis of MSTB, and chemotherapy, combined with supportive and immune-based therapies is effective for the treatment of MSTB.
Keywords:Multifocal skeletal tuberculosis   Immunosuppression
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号